Author | N | Initial β-hCG | Initial treatment | Medical treatment | Hospital stay | Negative β-hCG | Complications | Success |
---|---|---|---|---|---|---|---|---|
Fisch et al. [56] | 1 | 102,000 | SMTX | MTX 50 mg intrasaccular | 11 | 7 | – | 1/1 |
Moon et al. [38] | 1 | 47,200 | Laparoscopic CS | MTX | N/A | N/A | N/A | 1/1 |
Tulandi et al. [39] | 1 | 2086 | Laparoscopic CR | MTX | N/A | N/A | N/A | 1/1 |
Takeda et al. [94] | 1 | 16,100 | Laparoscopic CS | MTX | 30 | N/A | N/A | 1/1 |
Araujo et al. [64] | 1 | 4815 | SMTX | LMTX (50 mg), UG | N/A | N/A | – | 1/1 |
Fujioka et al. [65] | 1 | 11,430 | SMTX | Dactinomycin 12 μg/kg IV | N/A | N/A | – | 1/1 |
MacRae et al. [40] | 1 | 7237 | Laparoscopic CR | SMTX | N/A | N/A | N/A | 1/1 |
Ng et al. [41] | 9 | N/A | Laparoscopy | SMTX | N/A | N/A | N/A | 9/9 |
Sahoo et al. [95] | 1 | 12,000 | Laparoscopy | SMTX | N/A | N/A | – | 1/1 |
Moon et al. [14] | 1 | 9836 | Laparoscopic CS | SMTX | N/A | N/A | N/A | 1/1 |
Kato et al. [68] | 1 | 90,000 | SMTX | LMTX (25 mg) | N/A | 6 | – | 1/1 |
Surbone et al. [74] | 1 | N/A | LMTX | SMTX | N/A | N/A | N/A | 0/1 |
Douysset et al. [46] | 2 | N/A | Laparoscopic CR | MTX | N/A | N/A | N/A | 2/2 |
 | 1 | N/A | Laparoscopic CS | MTX | N/A | N/A | N/A | 1/1 |
Poon et al. [96] | 2 | 3658–89,968 | Expectant | LMTX | N/A | N/A | N/A | 2/2 |
Wang et al. [50] | 1 | N/A | Laparoscopic CS | MTX 20 mg IM for 5 days | N/A | 4 | – | 1/1 |
Lee et al. [51] | 5 | N/A | Laparoscopy | MTX multiple dose regimen | N/A | N/A | – | 5/5 |